Alexis Peyroles

Alexis Peyroles

Chief Executive Officer at Ose Immunotherapeutics, Inc.

Net worth: 6 M $ as of 29/04/2024

Health Technology
Consumer Services
Distribution Services

Network origin in Alexis Peyroles first degree

EntityEntity typeIndustry
Public Company Pharmaceuticals: Major 20

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Alexis Peyroles via their personal network

CompanySectorRelated peopleMain position
FTI CONSULTING, INC. Miscellaneous Commercial Services

Elsy Boglioli Hofman

Director/Board Member

Investment Managers

David de Weese

Walter Flamenbaum

Private Equity Investor

Corporate Officer/Principal

Miscellaneous Commercial Services

Guy Chatelain

Corporate Officer/Principal

VALERIO THERAPEUTICS Pharmaceuticals: Major

Jean Théron

Françoise Bono

Founder

Chief Tech/Sci/R&D Officer

Investment Managers

Guy Chatelain

Chief Executive Officer

Miscellaneous Commercial Services

Maryvonne Hiance

Director/Board Member

Institut National Polytechnique de Grenoble College/University

Maryvonne Hiance

Undergraduate Degree

Miscellaneous Commercial Services

Bernard Vanhove

Sophie Brouard

Corporate Officer/Principal

Corporate Officer/Principal

École des Hautes Études Commerciales de Paris College/University

Gerard A. Tardy

Guy Chatelain

Linda Lebon

Undergraduate Degree

Masters Business Admin

Masters Business Admin

Miscellaneous Commercial Services

Guy Chatelain

Corporate Officer/Principal

Miscellaneous Commercial Services

Maryvonne Hiance

Chairman

Miscellaneous Commercial Services

Anne-Laure Autret-Cornet

Corporate Officer/Principal

Ecole des Ingenieurs College/University

Maryvonne Hiance

Undergraduate Degree

Biotechnology

Didier Hoch

Chairman

Miscellaneous Commercial Services

Maryvonne Hiance

Chief Operating Officer

Université Catholique de Louvain College/University

Bernard Vanhove

Doctorate Degree

Strategic Ventures & Research, Inc.

Maryvonne Hiance

Founder

Electrical Products

Maryvonne Hiance

Corporate Officer/Principal

General Government

Bernard Vanhove

Sophie Brouard

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Guy Chatelain

Director/Board Member

Swiss Bar Association

Guy Chatelain

Corporate Officer/Principal

Geneva Association of Business Law

Guy Chatelain

Corporate Officer/Principal

Geneva Bar Association

Guy Chatelain

Corporate Officer/Principal

Packaged Software

Elsy Boglioli Hofman

Director/Board Member

Ecole Supérieure De Commerce D'angers College/University

Anne-Laure Autret-Cornet

Undergraduate Degree

Indufina, Industrielle et Financière Holding Genève SA

Guy Chatelain

Director/Board Member

Wholesale Distributors

Guy Chatelain

Director/Board Member

Miscellaneous Commercial Services

Maryvonne Hiance

Director/Board Member

Fondation pour l’Université de Lyon

Didier Hoch

Chairman

Biotechnology

Bernard Vanhove

Chief Operating Officer

Aventis Pharma International SAS

Didier Hoch

Corporate Officer/Principal

Investment Managers

Elsy Boglioli Hofman

Consultant / Advisor

Underground Charity Foundation

Didier Hoch

Chairman

Fondation Universite Grenoble Alpes

Didier Hoch

Director/Board Member

Goliver Therapeutics

Didier Hoch

Director/Board Member

Biotechnology

Elsy Boglioli Hofman

Director/Board Member

Miscellaneous Commercial Services

Didier Hoch

Founder

Miscellaneous Commercial Services

Maryvonne Hiance

Founder

Healthtech For Care

Maryvonne Hiance

Chairman

Threefrog Therapeutics

Elsy Boglioli Hofman

Chairman

PHAXIAM THERAPEUTICS S.A. Pharmaceuticals: Major

Didier Hoch

Chairman

Pharmaceuticals: Other

Elsy Boglioli Hofman

Director/Board Member

Pharmaceuticals: Major

Emile Loria

Guy Chatelain

Founder

Director/Board Member

Statistics

International

France 34
Switzerland 9
United States 7
Belgium 2
Netherlands 2

Sectoral

Health Technology 15
Commercial Services 12
Consumer Services 6
Finance 4
Producer Manufacturing 2

Operational

Director/Board Member 75
Corporate Officer/Principal 45
Chairman 23
Independent Dir/Board Member 20
Chief Executive Officer 16